Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05386706Completed
Randomised, open-label trial (2 arms), sponsored by Shanghai Tenth People's Hospital. Primary endpoint: Homeostasis model assessment of insulin resistance at 3 months. Started Jun 2022; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05386706.